AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 45 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $146,000 | -24.0% | 67,517 | 0.0% | 0.00% | – |
| Q2 2022 | $192,000 | +40.1% | 67,517 | +106.4% | 0.00% | – |
| Q1 2022 | $137,000 | -19.4% | 32,704 | 0.0% | 0.00% | – |
| Q4 2021 | $170,000 | -10.5% | 32,704 | +12.8% | 0.00% | – |
| Q3 2021 | $190,000 | +33.8% | 28,984 | +35.8% | 0.00% | – |
| Q2 2021 | $142,000 | +125.4% | 21,337 | +95.9% | 0.00% | – |
| Q1 2021 | $63,000 | -35.1% | 10,891 | 0.0% | 0.00% | – |
| Q4 2020 | $97,000 | -3.0% | 10,891 | +25.8% | 0.00% | – |
| Q3 2020 | $100,000 | -27.5% | 8,660 | 0.0% | 0.00% | – |
| Q2 2020 | $138,000 | +411.1% | 8,660 | +87.3% | 0.00% | – |
| Q1 2020 | $27,000 | -41.3% | 4,623 | +31.5% | 0.00% | – |
| Q4 2019 | $46,000 | +2200.0% | 3,515 | +2307.5% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 146 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 146 | +217.4% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $38,130,000 | 36.42% |
| FRAZIER MANAGEMENT LLC | 3,746,857 | $19,446,000 | 1.50% |
| TFG Asset Management GP Ltd | 2,700,000 | $14,013,000 | 0.84% |
| Nantahala Capital Management | 4,077,509 | $21,162,000 | 0.74% |
| Ikarian Capital, LLC | 544,819 | $2,827,000 | 0.42% |
| HARBOR CAPITAL ADVISORS, INC. | 211,319 | $1,097,000 | 0.40% |
| Blackstone Inc. | 17,985,611 | $93,345,000 | 0.23% |
| Resolute Capital Asset Partners LLC | 65,115 | $338,000 | 0.22% |
| MYDA Advisors LLC | 125,000 | $649,000 | 0.17% |
| Eversept Partners, LP | 401,540 | $2,083,993 | 0.13% |